Monitor for the actual sale on Form 4 and any subsequent insider selling patterns. The CEO's intent to sell a large block after a stock option exercise could pressure the stock near-term. Watch for any accompanying negative news or guidance changes in upcoming filings.
Price Chart
Executive Summary
CEO Stephane Bancel filed a Form 144 on August 5, 2026, indicating intent to sell 499,246 shares of Moderna common stock, valued at approximately $28.96 million. The shares were acquired via stock option exercise, and the sale is planned through Fidelity Brokerage Services. This is a material insider sale by the CEO, representing a notable portion of his holdings, and may signal a lack of near-term confidence or a planned diversification event.
Key Facts
- CEO Stephane Bancel filed a Form 144 to sell 499,246 shares of Moderna common stock.
- The proposed sale value is approximately $28,956,268 based on the filing date (August 5, 2026).
- Shares were acquired via stock option exercise on the same date (August 5, 2026).
- The sale is planned through Fidelity Brokerage Services LLC.
- Bancel is listed as both an Officer and Director of Moderna.
- The filing was made on August 5, 2026, and accepted the same day.
Financial Impact
CEO proposes to sell ~$28.96 million worth of shares, representing a significant insider monetization event.
Risk Factors
- CEO selling a large stake may signal lack of confidence or foreshadow weak fundamentals.
- The sale could increase selling pressure and dampen investor sentiment.
- Option exercise and immediate sale may be viewed as compensation monetization, but size is notable.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (MRNA) — Batch item 1 | 0001959173-26-005661 |
| Document: 0001959173-26-005661-index.html | 0001959173-26-005661 |
| Document: 0001959173-26-005661.txt | 0001959173-26-005661 |
| 144 Filing (MRNA) — Batch item 4 | 0001959173-26-005661 |
| Document: 0001959173-26-005661-index.html | 0001959173-26-005661 |
| Document: 0001959173-26-005661.txt | 0001959173-26-005661 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 2d ago | ANALYST-DOWNGRADE | — | awaiting T+5 | — | — |
Sep 3, 2026 29d ago | ANALYST-DOWNGRADE | $148.87 $143.97 | ▲ +3.29% | ▲ +2.14% | $190.01 (−27.63%) |
Aug 31, 2026 4w ago | Court Ruling | $140.19 $140.33 | ▼ −0.10% | ▼ −0.24% | $190.01 (−35.54%) |
Aug 25, 2026 5w ago | ANALYST-UPGRADE | $158.83 $154.27 | ▼ −2.87% | ▼ −2.33% | $190.01 (+19.63%) |
Aug 19, 2026 6w ago | ANALYST-UPGRADE | $174.38 $149.66 | ▼ −14.18% | ▼ −13.79% | $190.01 (+8.96%) |
Aug 5, 2026 8w ago | 144 | $56.26 $63.67 | ▼ −13.18% | ▼ −12.83% | $190.01 (−237.77%) |
Jul 31, 2026 9w ago | 8-K | $54.82 $59.17 | ▲ +7.94% | ▲ +4.42% | $190.01 (+246.61%) |
Jul 10, 2026 11w ago | 3 | $67.01 $61.82 | ▼ −7.75% | ▼ −6.96% | $190.01 (+183.55%) |
Jul 8, 2026 12w ago | 8-K | $73.80 $67.44 | ▼ −8.62% | ▼ −9.48% | $190.01 (+157.47%) |
Jun 18, 2026 15w ago | 144 | $63.96 $59.75 | ▼ −6.58% | ▼ −4.92% | $190.01 (+197.08%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access